Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Vyriad, Inc.

Clinical trials sponsored by Vyriad, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • Engineered virus joins forces with immunotherapy to fight resistant cancers Results expected Oct 2026 (estimated)
  • Can a single infusion build Cancer-Killing cells inside the body? Results expected Aug 2027 (estimated)
Browse trials soon ready across all sponsors →
Not yet recruiting 1 Not yet finished but already full! 2
Sort by
  • Can a single infusion build Cancer-Killing cells inside the body?

    Cure Not yet recruiting

    This phase 1 trial tests VV169, a therapy that aims to create CAR-T cells inside the body to fight multiple myeloma. Researchers give VV169 as an infusion to adults whose cancer has returned or stopped responding to at least three prior treatments. The study focuses on safety, fi…

    Phase 1 • Sponsor: Vyriad, Inc. • Aim: Cure

    Last updated Sep 10, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space